Daniel Hohn

Head Of Sales Biosimilars at Stada Group

Daniel Hohn has extensive work experience in the pharmaceutical and healthcare industry. Daniel currently holds the position of Head of Sales Biosimilars at STADA Group since 2024. Prior to that, they worked at MEDICE - The Health Family where they held various roles including Head of Business Intelligence & Pricing OTC from 2020 to 2023, Marketing Manager OTC from 2021 to 2023, Head of Trade Marketing OTC in 2021, and Vertriebsleiter Mitte OTC in 2020. Before joining MEDICE, they worked at Reckitt as Leiter Key Account Management OTC in 2019, Regionaler Vertriebsleiter OTC from 2016 to 2018, Key-Account-Manager OTC MOP/Versandhandel from 2015 to 2016, Junior-Key-Account-Manager OTC MOP/ Versandhandel from 2014 to 2015, and Außendienst OTC from 2008 to 2013. Daniel started their career at Alliance Healthcare as an Assistent der Geschäftsleitung from 2007 to 2008.

Daniel Hohn obtained a Bachelor Professional of Trade and Commerce degree in Betriebswirtschafts from IFM Institut für Managementlehre in Frankfurt am Main. Daniel completed their studies from 2009 to 2011.

Location

Bad Vilbel, Germany

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Stada Group

14 followers

Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.


Industries

Employees

10,000+

Links